EPALEX
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.
EPALEX
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.epalex.com
Total Employee:
1+
Status:
Active
Contact:
(650) 346-3380
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Apache Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Current Employees Featured
Founder
Official Site Inspections
http://www.epalex.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: 199.223.115.138
- IP address: 199.223.115.138
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
